Latest Pharmacy Distribution News

Page 2 of 2
LTR Pharma reports compelling clinical results for its nasal spray ED treatment SPONTAN®, demonstrating rapid absorption and strong safety, alongside strategic partnerships and a robust $34 million cash position.
Ada Torres
Ada Torres
30 Jan 2025
Immuron Limited reports a striking 70% quarter-on-quarter increase in Travelan® sales, driven by expanded pharmacy distribution in Australia and North America.
Victor Sage
Victor Sage
17 Jan 2025

Browse the archive

Full archive